Application of a patient-derived xenograft model in cytolytic viral activation therapy for nasopharyngeal carcinoma
Authors:
Open Access
- 24 September 2015
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 6 (31) , 31323-31334
Abstract
Application of a patient-derived xenograft model in cytolytic viral activation therapy for nasopharyngeal carcinomaKeywords
This publication has 36 references indexed in Scilit:
- Cytolytic Virus Activation Therapy for Epstein-Barr Virus–Driven TumorsClinical Cancer Research, 2012
- Histone deacetylase inhibitors are potent inducers of gene expression in latent EBV and sensitize lymphoma cells to nucleoside antiviral agentsBlood, 2012
- Patient-Derived Xenografts of Non Small Cell Lung Cancer: Resurgence of an Old Model for Investigation of Modern Concepts of Tailored Therapy and Cancer Stem CellsJournal of Biomedicine and Biotechnology, 2012
- Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomesNature Medicine, 2011
- Personalizing Cancer Treatment in the Age of Global Genomic Analyses: PALB2 Gene Mutations and the Response to DNA Damaging Agents in Pancreatic CancerMolecular Cancer Therapeutics, 2011
- Molecular and Therapeutic Potential and Toxicity of Valproic AcidJournal of Biomedicine and Biotechnology, 2010
- The Epstein-Barr Virus (EBV)-Encoded Protein Kinase, EBV-PK, but Not the Thymidine Kinase (EBV-TK), Is Required for Ganciclovir and Acyclovir Inhibition of Lytic Viral ProductionJournal of Virology, 2010
- Establishment of Patient-Derived Non–Small Cell Lung Cancer Xenografts as Models for the Identification of Predictive BiomarkersClinical Cancer Research, 2008
- Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumorsNature Medicine, 2008
- Valproic Acid Enhances the Efficacy of Chemotherapy in EBV-Positive Tumors by Increasing Lytic Viral Gene ExpressionCancer Research, 2006